UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Pure Red-Cell Aplasia and Epoetin Therapy

The New England journal of medicine, 2004-09, Vol.351 (14), p.1403-1408

2004

Volltextzugriff (PDF)

Spending on Hepatitis C Antivirals in the United States, 2008-2014

Value in health, 2015-05, Vol.18 (3), p.A228-A228

2015

Volltextzugriff (PDF)

Prioritizing Comparative‐Effectiveness Research Topics via Stakeholder Involvement: An Application in COPD

Clinical pharmacology and therapeutics, 2011-12, Vol.90 (6), p.888-892

2011

Volltextzugriff (PDF)

The validity of Algorithms for identifying suspected and confirmed Heparin-induced Thrombocytopenia

Value in health, 2015-05, Vol.18 (3), p.A292-A292

2015

Volltextzugriff (PDF)

Comparative effectiveness and safety of Argatroban and Bivalirudin in Patients with suspected Heparin-induced Thrombocytopenia

Value in health, 2015-05, Vol.18 (3), p.A293-A293

2015

Volltextzugriff (PDF)

Clinical and economic burden of fractures in patients with renal osteodystrophy

Clinical nephrology, 2007-04, Vol.67 (4), p.201

2007

Volltextzugriff (PDF)

Economic Considerations in Alzheimer's Disease

Pharmacotherapy, 1998-03, Vol.18 (2P2), p.68-73

1998

Volltextzugriff (PDF)

Exploring the use of social network methods in designing healthcare quality improvement teams

Social science & medicine (1982), 2010-09, Vol.71 (6), p.1119-1130

2010

Volltextzugriff (PDF)

Methods to Assess the Economic Outcomes of Clinical Pharmacy Services

Pharmacotherapy, 2000-10, Vol.20 (10P2), p.243S-252S

Schumock, Glen T.

2000

Volltextzugriff (PDF)

DM2 ADHERENCE TO DPP-4 INHIBITORS VERSUS PIOGLITAZONE IN TYPE 2 DIABETES PATIENTS WITH CHRONIC KIDNEY DISEASE: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS

Value in health, 2019-05, Vol.22, p.S39-S39

2019

Volltextzugriff (PDF)

Focusing on the preventability of adverse drug reactions

Hospital pharmacy (Philadelphia), 1992-06, Vol.27 (6), p.538

1992

Volltextzugriff (PDF)

Characteristics Associated with Ability to Prevent Adverse Drug Reactions in Hospitalized Patients

Pharmacotherapy, 1998-11, Vol.18 (6), p.1284-1289

1998

Volltextzugriff (PDF)

Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

Value in health, 2017-10, Vol.20 (9), p.A655

2017

Volltextzugriff (PDF)

PHP22 - Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

Value in health, 2017-10, Vol.20 (9), p.A655-A655

2017

Volltextzugriff (PDF)

Thalidomide-associated deep vein thrombosis and pulmonary embolism

The American journal of medicine, 2002-11, Vol.113 (7), p.603-606

2002

Volltextzugriff (PDF)

THE IMPACT OF THE FDA’S UNAPPROVED DRUGS INITIATIVE ON EXPENDITURES FOR ORAL COLCHICINE IN THE UNITED STATES

Value in health, 2017-05, Vol.20 (5), p.A34

2017

Volltextzugriff (PDF)

PGI36 - Spending on Hepatitis C Antivirals in the United States, 2008-2014

Value in health, 2015-05, Vol.18 (3), p.A228-A228

2015

Volltextzugriff (PDF)

Economic Evaluations of Clinical Pharmacy Services-1988-1995

Pharmacotherapy, 1996-11, Vol.16 (6), p.1188-1208

1996

Volltextzugriff (PDF)

Economic considerations in the treatment and management of Alzheimer's disease

American journal of health-system pharmacy, 1998-11, Vol.55 (suppl 2), p.S17-S21

Schumock, GT

1998

Volltextzugriff (PDF)

National trends in prescription drug expenditures and projections for 2017

American journal of health-system pharmacy, 2017-08, Vol.74 (15), p.1158-1173

2017

Volltextzugriff (PDF)

Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter

The American journal of cardiology, 2000-02, Vol.85 (4), p.503-506

2000

Volltextzugriff (PDF)

Efficacy and safety of warfarin management in US anticoagulation clinic

Journal of thrombosis and thrombolysis, 2008-02, Vol.25 (1), p.131-131

2008

Volltextzugriff (PDF)

We've Been Shown the Money, and We Now Know How to Spend It

Pharmacotherapy, 1999-12, Vol.19 (12), p.1349-1351

Schumock, Glen T.

1999

Volltextzugriff (PDF)

PMS17 - Utilization of Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Juvenile Idiopathic Arthritis

Value in health, 2016-05, Vol.19 (3), p.A227-A227

2016

Volltextzugriff (PDF)

Utilization of Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Juvenile Idiopathic Arthritis

Value in health, 2016-05, Vol.19 (3), p.A227-A227

2016

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(108)
Tagungsberichte
(2)

Sprache

Englisch
(110)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Pure Red-Cell Aplasia and Epoetin Therapy

Spending on Hepatitis C Antivirals in the United States, 2008-2014

Prioritizing Comparative‐Effectiveness Research Topics via Stakeholder Involvement: An Application in COPD

The validity of Algorithms for identifying suspected and confirmed Heparin-induced Thrombocytopenia

Comparative effectiveness and safety of Argatroban and Bivalirudin in Patients with suspected Heparin-induced Thrombocytopenia

Clinical and economic burden of fractures in patients with renal osteodystrophy

Economic Considerations in Alzheimer's Disease

Exploring the use of social network methods in designing healthcare quality improvement teams

Methods to Assess the Economic Outcomes of Clinical Pharmacy Services

DM2 ADHERENCE TO DPP-4 INHIBITORS VERSUS PIOGLITAZONE IN TYPE 2 DIABETES PATIENTS WITH CHRONIC KIDNEY DISEASE: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS

Focusing on the preventability of adverse drug reactions

Characteristics Associated with Ability to Prevent Adverse Drug Reactions in Hospitalized Patients

Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

PHP22 - Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

Thalidomide-associated deep vein thrombosis and pulmonary embolism

THE IMPACT OF THE FDA’S UNAPPROVED DRUGS INITIATIVE ON EXPENDITURES FOR ORAL COLCHICINE IN THE UNITED STATES

PGI36 - Spending on Hepatitis C Antivirals in the United States, 2008-2014

Economic Evaluations of Clinical Pharmacy Services-1988-1995

Economic considerations in the treatment and management of Alzheimer's disease

National trends in prescription drug expenditures and projections for 2017

Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter

Efficacy and safety of warfarin management in US anticoagulation clinic

We've Been Shown the Money, and We Now Know How to Spend It

PMS17 - Utilization of Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Juvenile Idiopathic Arthritis

Utilization of Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Juvenile Idiopathic Arthritis

Suchergebnisse filtern